Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Anifrolumab
Study Purpose: This study was done to learn how anifrolumab
works in participants with active proliferative
lupus nephritis
Protocol Number: D3461C00007
Thank you!
Thank you for taking part in the clinical study for the study drug anifrolumab.
You and all of the participants helped researchers learn more about anifrolumab to help people
with active proliferative lupus nephritis.
AstraZeneca AB sponsored this study and believes it is important to share the results of the
study with you and the public. An independent non-profit organization called CISCRP helped
prepare this summary of the study results for you. We hope it helps you understand and feel
proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1